4 reports

  • ASTHMA - PIPELINE BY OPKO HEALTH INC, H2 2018
  • Indication Name

Asthma - Overview Asthma - Therapeutics Development PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ASTHMA, H## 2018 NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ASTHMA, H## 2018 Pre-Registration ## ## Phase III ## ## Phase II ## ## Phase I ## ## IND/ CTA Filed ## ## Preclinical ## ## Di

  • Asthma
  • United States
  • Company
  • Product Initiative
  • AstraZeneca PLC
  • ASTHMA - PIPELINE BY ORBIS BIOSCIENCES INC, H1 2018
  • ASTHMA - PIPELINE BY ORCHID PHARMA LTD, H1 2018

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## IND ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## PC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Un ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Dis ## ## ##

  • Asthma
  • Pharmaceutical
  • Research And Development
  • Therapy
  • AstraZeneca PLC

Its women' s health portfolio includes contraceptives and other products including Plan B One-Step OTC/ Rx (levonorgestrel), an emergency oral contraceptive; Quartette (levonorgestrel/ ethinyl estradiol and ethinyl estradiol) tablets, an extended-regimen oral

  • Asthma
  • Pharmaceutical
  • Company Financials
  • Market Size
  • Teva Pharmaceutical Industries Ltd.
  • ASTHMA - PIPELINE BY OPKO HEALTH INC
  • ASTHMA - PIPELINE BY ORBIS BIOSCIENCES INC

contraceptives, and animal health.

  • Asthma
  • Pharmaceutical
  • Company
  • Product Initiative
  • AstraZeneca PLC